Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards $11M for Biomarker Studies Under Early Detection Research Network

NEW YORK, May 13 (GenomeWeb News) - The National Cancer Institute has awarded 13 grants worth a total of $11 million to fund research for the next five years under its Early Detection Research Network, the agency said yesterday.


Four of the grants go to institutions not previously funded by EDRN, whose goal is to establish validated biological markers that are ready for large-scale clinical testing. The funding covers three of the network's four components: clinical epidemiology and validation centers, biomarker reference laboratories, and a data management and coordinating center, as well as an informatics center. Funding for the fourth component, biomarker development laboratories, was awarded late last year.


Funding for epidemiology and validation centers goes to the Universityof Michigan, Brigham and Women's Hospital, the FoxChaseCancerCenter, CreightonUniversityin Omaha, Johns Hopkins University, New YorkUniversity School of Medicine, BethIsraelDeaconessMedicalCenter, University of Texas Health Science Center, and the Centers for Disease Control and Prevention.


Biomarkers reference laboratories funding was awarded to the National Institute of Standards and Technology, JohnsHopkinsUniversity, the Universityof California, Los Angeles, the Universityof Alabama, and the Universityof Maryland.


The FredHutchinsonCancerCenterreceived funding for the data management and coordinating center, and the National Aeronautics and Space Administration California Institute of Technology for the informatics center.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.